Roxana Mehran, MD, FSCAI is a Mount Sinai Professor in Cardiovascular Clinical Research and Outcomes and director of interventional cardiovascular research and clinical trials at The Zena and Michael A. Weiner Cardiovascular Institute at The Icahn School of Medicine at Mount Sinai, New York, NY. Dr. Mehran completed her training in internal medicine at the University of Connecticut, where she also served as chief medical resident before continuing with fellowships in both cardiovascular disease and interventional cardiology at Mount Sinai Medical Center.

Dr. Mehran is internationally recognized for her work in multicenter, multinational clinical trials, specializing in complex data analyses. She has developed several risk scores for bleeding and acute kidney injury to identify patients at risk for these complications. Previously (2004-2010), Dr. Mehran was an associate professor of medicine and director of outcomes research, data coordinating and analysis at the Center of Interventional Vascular Therapies at Columbia University, where she led a variety of projects focused on outcomes of patients undergoing percutaneous coronary intervention (PCI). She is renowned for her vast experience working with regulatory agencies to design and conduct clinical trials. Currently, she is one of several lead investigators who collaborate with the FDA to develop standard definitions for clinical trials in cardiovascular disease.